TCT 2024 Meeting Coverage

Get ACC's full coverage of the latest science from TCT 2024 – including trial summaries, news stories, journal scans and more.

Efficacy and Safety of Olezarsen in Managing Hypertriglyceridemia: BRIDGE–TIMI 73a Trial

The trial results emphasize the potential of olezarsen as a novel RNA therapeutic for managing hypertriglyceridemia in patients at high cardiovascular risk.

Renew Your ACC Membership

Join us in 2025 as we work to transform the future of cardiovascular care together.

Latest In Cardiology

Products

Engage

Quick Links

Events and Conferences

Join

Memberships

Fellow of the ACC (FACC)

Earn the ultimate recognition. Fellowship identifies you to peers and patients as a cardiovascular professional at the top of your field.

Cardiovascular Team

Join a vibrant community of nurses, PAs, clinical pharmacists, technologists and rehab specialists.

International Associate

Join a global community dedicated to reducing the burden of CV disease worldwide and access resources that help you advance your knowledge and expand your network.

Benefits

Unlock access to all 10 JACC Journals, exclusive networking opportunities with 56,000 cardiovascular professionals, deep discounts on educational opportunities and more.

Learn More  
The ACC is our community to learn from one another and grow with each other. United, we have the ability to advocate for our patients and profession. Nkechinyere Ijioma, MBBS, FACC

ACC Digital Family